Our Pricing

Get £10 off Your First Mounjaro Order Today

Searching for Mounjaro £10 off first order UK deals? Cured Pharmacy offers genuine UK-licensed Mounjaro (tirzepatide) injections from £135.00, with transparent pricing, free clinical consultations under three minutes, and discreet next-day delivery across the UK. Our GPhC-registered team ensures every patient receives expert guidance and MHRA-approved medication tailored to their weight loss goals.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing synergistic effects on appetite regulation, insulin sensitivity, and energy expenditure.

In the landmark SURPASS-3 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — substantially greater than comparator treatments [1]. Tirzepatide works by slowing gastric emptying, enhancing satiety signals to the brain, and improving glycaemic control, making it particularly effective for patients with obesity and related metabolic conditions [2].

Clinical trials demonstrate that Mounjaro may help patients lose significant weight when combined with a reduced-calorie diet and increased physical activity, though individual results vary based on adherence, baseline BMI, and metabolic factors [1][3].

Mounjaro Dosing Schedule and What to Expect

Mounjaro is administered as a once-weekly subcutaneous injection using the KwikPen device, which features a hidden needle and simple push-button mechanism suitable for self-administration at home. Your UK prescriber will determine your starting dose based on your medical history, current medications, and weight loss objectives.

The standard titration schedule begins with 2.5mg weekly for four weeks, increasing gradually to minimise gastrointestinal side effects such as nausea or diarrhoea [1]. Most patients progress through 5mg, 7.5mg, 10mg, and 12.5mg doses before reaching the 15mg maintenance dose, though your prescriber may adjust this based on tolerability and clinical response.

During the first eight to twelve weeks, patients typically notice reduced appetite, smaller portion sizes, and decreased food cravings. Weight loss becomes more pronounced after the first month, with peak efficacy observed between weeks 36 and 72 in clinical trials [1][3]. Regular follow-up consultations with your prescriber ensure safe dose escalation and monitoring for potential side effects.

Managing Side Effects During Titration

The most common side effects reported in clinical trials include nausea (occurring in up to 30% of patients), diarrhoea, constipation, and mild injection site reactions [1]. These symptoms are typically mild to moderate and diminish as your body adjusts to each dose level. Eating smaller, more frequent meals and avoiding high-fat foods can help minimise gastrointestinal discomfort during the initial weeks.

Comparing Mounjaro to Other Weight Loss Treatments

UK patients now have access to several prescription weight loss medications, each with distinct mechanisms, efficacy profiles, and administration schedules. Understanding these differences helps you and your prescriber select the most appropriate treatment for your individual circumstances.

Wegovy (semaglutide) is a once-weekly injectable GLP-1 receptor agonist that demonstrated an average weight loss of 14.9% over 68 weeks in the STEP 1 trial [4]. Saxenda (liraglutide) requires daily injections and showed an average 8% body weight reduction over 56 weeks in clinical studies [5]. Oral medications such as Orlistat work by blocking fat absorption in the digestive system, producing more modest weight loss of approximately 5-10% when combined with dietary changes [6].

Head-to-head comparisons suggest tirzepatide may produce greater weight loss than semaglutide-based treatments, though individual responses vary significantly [2][7]. Your choice should consider factors including injection frequency preferences, side effect tolerance, cost considerations, and any existing medical conditions such as type 2 diabetes.

Who Is Suitable for Mounjaro Treatment?

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, dyslipidaemia, or obstructive sleep apnoea [1]. It is not suitable for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. All patients require clinical assessment by a UK prescriber before treatment can commence.

Why Choose Cured Pharmacy for Your Mounjaro Prescription

As a fully registered UK online pharmacy (GPhC Registration Number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), Cured Pharmacy provides genuine MHRA-licensed Mounjaro with complete clinical oversight and pharmaceutical care. Our service combines transparent upfront pricing, rapid prescriber consultations, and discreet delivery to offer a convenient alternative to traditional GP appointments.

Unlike some online services, we display exact treatment costs before you begin your consultation, eliminating surprise fees or hidden charges. Our UK-registered clinical team reviews every consultation within hours, and approved prescriptions are dispensed from our GPhC-registered premises with next-day delivery options available across England, Scotland, Wales, and Northern Ireland.

Every Mounjaro pen supplied by Cured Pharmacy is sourced directly from licensed UK wholesalers and stored in temperature-controlled pharmaceutical facilities to maintain product integrity. We provide comprehensive patient information leaflets, injection technique guidance, and ongoing support throughout your weight loss journey.

The Clinical Consultation Process at Cured Pharmacy

Beginning your Mounjaro treatment requires a brief online consultation that typically takes under three minutes to complete. You'll answer questions about your medical history, current medications, previous weight loss attempts, and any relevant health conditions that might affect prescribing decisions.

A UK-registered prescriber reviews your consultation responses to determine whether Mounjaro is clinically appropriate and safe for you. This assessment considers contraindications, potential drug interactions, and individual risk factors. If approved, your prescription is sent electronically to our dispensary team, who prepare your medication for dispatch.

Should the prescriber identify any concerns or require additional information, they will contact you directly before processing your order. This ensures every patient receives personalised care equivalent to an in-person pharmacy consultation. Patients whose consultation indicates Mounjaro is not suitable will receive a full refund and guidance on alternative weight management options.

Ongoing Monitoring and Follow-Up Care

Successful weight loss treatment requires regular monitoring to assess progress, manage side effects, and adjust dosing as needed. Cured Pharmacy provides follow-up consultations at appropriate intervals, allowing your prescriber to review your response to treatment and make evidence-based recommendations. We encourage patients to track their weight, side effects, and any changes in health status between consultations to optimise treatment outcomes.

Maximising Weight Loss Results with Mounjaro

While Mounjaro is highly effective at reducing appetite and promoting weight loss, optimal results require commitment to lifestyle modifications alongside medication. Clinical trials demonstrating significant weight loss included structured dietary counselling and exercise programmes, emphasising that tirzepatide works best as part of a comprehensive approach [1][3].

Focus on nutrient-dense, whole foods including lean proteins, vegetables, whole grains, and healthy fats whilst reducing ultra-processed foods, sugary beverages, and excessive portion sizes. The appetite suppression effects of Mounjaro make it easier to adhere to a calorie-controlled diet, but conscious food choices remain essential for long-term success.

Incorporate regular physical activity suited to your current fitness level, gradually increasing intensity and duration as weight loss progresses and mobility improves. Resistance training helps preserve lean muscle mass during weight loss, whilst cardiovascular exercise enhances metabolic health and cardiovascular fitness. Many patients find that Mounjaro's effects on energy levels and physical comfort make exercise more enjoyable and sustainable than previous attempts [3].

Long-Term Weight Maintenance Strategies

Research indicates that maintaining weight loss after discontinuing GLP-1 medications can be challenging, with some patients regaining weight once treatment stops [7]. Developing sustainable eating patterns, regular exercise habits, and behavioural strategies during active treatment improves long-term maintenance outcomes. Your prescriber will work with you to determine the appropriate treatment duration based on your progress, goals, and individual circumstances.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on glycemic control and body weight in obesity: The SURMOUNT-1 extension. Nature Medicine, 29(10), 2571–2581. https://doi.org/10.1038/s41591-023-02597-w
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155
7. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle factors.